Mpakogiannis Konstantinos, Fousekis Fotios S, Elemes Stylianos, Mantellos Evangelos, Christaki Eirini, Katsanos Konstantinos H
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Division of Medical Oncology, Papageorgiou Hospital, School of Medicine, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece.
Antibiotics (Basel). 2025 Jul 2;14(7):670. doi: 10.3390/antibiotics14070670.
() is primarily associated with colonic disease, including pseudomembranous colitis. However, in rare instances, it may cause extraintestinal infectious and non-infectious manifestations, particularly in immunocompromised patients or those with significant underlying conditions.
A literature review was performed using PubMed, Embase, and Researchgate databases up to 15 February 2025. The following search strings were used: "extraintestinal manifestations", "extracolonic manifestations", "extraintestinal infections", "extracolonic infections", "", and "".
Extraintestinal manifestations of appear to represent fewer than 1% of all reported infections. The most frequently reported infectious complications include bacteremia and abdominopelvic infections and abscesses, often involving polymicrobial cultures, with the isolation of alongside microorganisms typically found in the normal intestinal microbiota. Rare non-infectious cases, such as reactive arthritis, have also been described. The underlying pathogenetic mechanism is believed to involve disruption of the intestinal barrier and translocation of bacteria or toxins to sterile sites.
Though rare, extraintestinal manifestations pose important clinical challenges. Better understanding of their mechanisms is essential for early recognition and appropriate management. Further research is warranted to define potential mechanisms and therapeutic approaches.
()主要与结肠疾病相关,包括伪膜性结肠炎。然而,在罕见情况下,它可能会引起肠外感染性和非感染性表现,尤其是在免疫功能低下的患者或有严重基础疾病的患者中。
截至2025年2月15日,使用PubMed、Embase和Researchgate数据库进行了文献综述。使用了以下检索词:“肠外表现”、“结肠外表现”、“肠外感染”、“结肠外感染”、“”和“”。
()的肠外表现似乎占所有报告感染的不到1%。最常报告的感染并发症包括菌血症和腹腔盆腔感染及脓肿,通常涉及多种微生物培养,同时分离出()以及正常肠道微生物群中常见的微生物。也描述了罕见的非感染性病例,如反应性关节炎。据信潜在的发病机制涉及肠道屏障的破坏以及细菌或毒素向无菌部位的移位。
尽管罕见,但()的肠外表现带来了重要的临床挑战。更好地了解其机制对于早期识别和适当管理至关重要。有必要进一步研究以确定潜在机制和治疗方法。